Proxy Votes Now

Home › Funds › BlackRock › BlackRock Advantage Small Cap Growth Fund

BlackRock Advantage Small Cap Growth Fund (CSGEX) proxy voting record 2025-2026

Fund family: BlackRock · Filed by BLACKROCK FUNDS (CIK 844779) · SEC series S000001507

Share classes and tickers: CSGEX (C000004049), PSGIX (C000004047)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 4,801 with, 40 against, 99 abstentions (not counted as with management); 3 items carried no recommendation. Shareholder proposals: 7 FOR, 18 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with BlackRock as a whole

The same two figures as BlackRock’s manager page (1,606,521 ballot items across 392 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsBlackRockItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)94.5%4,79593.6%1,355,861
Backed environmental and social shareholder proposals at US companiesn/a75.5%6,306

Where this fund voted differently from most BlackRock funds

Each ballot item this fund voted is set against the votes of the other BlackRock funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most BlackRock funds on 218 items (4.5% of the 4,890 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost BlackRock fundsMgmtResult
HAMILTON LANE INCORPORATED2025-09-04DIRECTOR: Hartley R. RogersForABSTAIN — 24 of 24 BlackRock fundsFor—
A10 NETWORKS, INC.2026-04-22To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified. Peter Y. ChungWithholdFOR — 23 of 23 BlackRock fundsAgainst—
CACTUS, INC.2026-05-12Election of Class II and Class III Directors Gary RosenthalAgainstFOR — 19 of 19 BlackRock fundsAgainst—
FIGS, INC.2026-06-03Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.ForAGAINST — 19 of 19 BlackRock fundsForApproved, 83.9% support
DXP ENTERPRISES, INC.2026-06-12DIRECTOR: Karen HoffmanAbstainFOR — 16 of 16 BlackRock fundsAgainst—
VARONIS SYSTEMS, INC.2026-06-01To approve, on a non-binding, advisory basis, the executive compensation of our named executive officers.AgainstFOR — 28 of 30 BlackRock fundsAgainstPassed (calculated), 91.2% support
AMPRIUS TECHNOLOGIES, INC.2026-06-11DIRECTOR: Kathleen BaylessAbstainFOR — 14 of 14 BlackRock fundsAgainst—
IES HOLDINGS, INC.2026-02-19DIRECTOR: DAVID B.GENDELLAbstainFOR — 13 of 13 BlackRock fundsAgainst—
IES HOLDINGS, INC.2026-02-19DIRECTOR: JOE D. KOSHKINForABSTAIN — 13 of 13 BlackRock fundsFor—
IES HOLDINGS, INC.2026-02-19DIRECTOR: TODD M. CLEVELANDForABSTAIN — 13 of 13 BlackRock fundsFor—
THE PENNANT GROUP, INC.2026-05-14Election of Directors Christopher R. ChristensenAgainstFOR — 13 of 13 BlackRock fundsAgainst—
THE PENNANT GROUP, INC.2026-05-14Election of Directors John G. Nackel, Ph.D.AgainstFOR — 13 of 13 BlackRock fundsAgainst—
EVERCORE INC.2026-06-10Approval of the Fourth Amended and Restated 2016 Evercore Inc. Stock Incentive Plan.AgainstFOR — 29 of 32 BlackRock fundsAgainstApproved, 68.0% support
DISC MEDICINE, INC.2026-06-18To elect each of the following Class III nominees to the Board of Directors as set forth below: Donald Nicholson, Ph.D.WithholdFOR — 12 of 12 BlackRock fundsAgainst—
UNITED STATES LIME & MINERALS, INC.2026-05-01DIRECTOR: A. M. DoumetAbstainFOR — 12 of 12 BlackRock fundsAgainst—
UNITED STATES LIME & MINERALS, INC.2026-05-01DIRECTOR: R. W. CardinForABSTAIN — 12 of 12 BlackRock fundsFor—
ANTERIX INC.2025-08-05Election of Director to hold office until the 2026 Annual Meeting of Stockholders and until their respective successors are elected and qualified: Leslie B. DanielsAgainstFOR — 12 of 12 BlackRock fundsAgainst—
ANTERIX INC.2025-08-05Election of Director to hold office until the 2026 Annual Meeting of Stockholders and until their respective successors are elected and qualified: Mahvash YazdiAgainstFOR — 12 of 12 BlackRock fundsAgainst—
ARRIVENT BIOPHARMA, INC.2026-06-18DIRECTOR: John Hohneker, M.D.AbstainFOR — 12 of 12 BlackRock fundsAgainst—
BLEND LABS, INC.2026-06-17DIRECTOR: Erin LantzForABSTAIN — 12 of 12 BlackRock fundsFor—
APPLIED DIGITAL CORPORATION2025-11-05Approve, on an advisory basis, the executive compensation of the Company's named executive officers as described in the proxy statement.ForAGAINST — 22 of 24 BlackRock fundsForPassed (calculated), 52.6% support
DAVE INC.2026-06-02Director Election Dan PrestonWithholdFOR — 11 of 11 BlackRock fundsAgainst—
FUBOTV INC.2025-09-30To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable by Fubo to our named executive officers in connection' with the transactions contemplated by the Business Combination Agreement.AgainstFOR — 22 of 24 BlackRock fundsAgainst—
BRAZE, INC.2026-06-30Advisory vote to approve the compensation of our named executive officers.ForAGAINST — 21 of 23 BlackRock fundsForApproved, 73.7% support
AMYLYX PHARMACEUTICALS, INC.2026-06-04Election of Directors: To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Paul FontWithholdFOR — 16 of 17 BlackRock fundsAgainstPassed (calculated), 94.8% support
Show all 218
Items 26 to 218.
CompanyMeetingItemThis fundMost BlackRock fundsMgmtResult
IDT CORPORATION2025-12-11Election of Directors: Judah SchorrAgainstFOR — 16 of 17 BlackRock fundsAgainstElected, 88.0% support
FIGS, INC.2026-06-03DIRECTOR: Melanie WhelanForABSTAIN — 10 of 10 BlackRock fundsFor—
MINERALYS THERAPEUTICS, INC.2026-05-21Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D.ForWITHHOLD — 15 of 16 BlackRock fundsForPassed (calculated), 60.6% support
OMEROS CORPORATION2026-06-18Election of Directors. Thomas J. CableAgainstFOR — 10 of 10 BlackRock fundsAgainst—
GRID DYNAMICS HOLDINGS, INC.2025-12-23The approval, on a non-binding advisory basis, of the compensation of our named executive officers.ForAGAINST — 24 of 27 BlackRock fundsForApproved, 56.8% support
SOLID BIOSCIENCES INC.2026-06-10Election of Class II Directors Adam StoneWithholdFOR — 10 of 10 BlackRock fundsAgainst—
NIOCORP DEVELOPMENTS LTD.2026-04-06DIRECTOR: Dean C. KehlerAbstainFOR — 10 of 10 BlackRock fundsAgainst—
NIOCORP DEVELOPMENTS LTD.2026-04-06DIRECTOR: Michael G. MaselliAbstainFOR — 10 of 10 BlackRock fundsAgainst—
NIOCORP DEVELOPMENTS LTD.2026-04-06DIRECTOR: Nilsa Guerrero-MahonAbstainFOR — 10 of 10 BlackRock fundsAgainst—
NIOCORP DEVELOPMENTS LTD.2026-04-06DIRECTOR: Peter OliverAbstainFOR — 10 of 10 BlackRock fundsAgainst—
VERRA MOBILITY CORPORATION2026-05-19DIRECTOR: John H. RexfordAbstainFOR — 15 of 16 BlackRock fundsAgainst—
PINNACLE FINANCIAL PARTNERS, INC.2025-11-06A proposal to approve, on an advisory (non-binding) basis, the merger-related compensation payments that will or may be paid to Pinnacle's named executive officers in connection with the transactions contemplated by the merger agreement.ForAGAINST — 36 of 42 BlackRock fundsFor—
APPLIED DIGITAL CORPORATION2025-11-05Election of Directors Richard NottenburgForWITHHOLD — 14 of 15 BlackRock fundsFor—
CORCEPT THERAPEUTICS INCORPORATED2026-05-21Election of Directors. David L. MahoneyForWITHHOLD — 21 of 24 BlackRock fundsFor—
IES HOLDINGS, INC.2026-02-19ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.ForAGAINST — 21 of 24 BlackRock fundsForApproved, 92.8% support
RUSH ENTERPRISES, INC.2026-05-19DIRECTOR: Elaine MendozaForABSTAIN — 21 of 24 BlackRock fundsFor—
CHAMPION HOMES, INC.2025-07-24Election of Director to serve until the next annual meeting of shareholders or until a successor has been duly elected and qualified: Tawn KelleyWithholdFOR — 17 of 19 BlackRock fundsAgainst—
ADMA BIOLOGICS, INC.2026-06-02To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified. Alison C. FingerWithholdFOR — 17 of 19 BlackRock fundsAgainst—
BLUE BIRD CORPORATION2026-03-11DIRECTOR: Douglas GrimmAbstainFOR — 13 of 14 BlackRock fundsAgainst—
ALPHATEC HOLDINGS, INC.2026-06-10To elect seven persons to our Board of Directors Mortimer Berkowitz IIIWithholdFOR — 13 of 14 BlackRock fundsAgainst—
ALPHATEC HOLDINGS, INC.2026-06-10To elect seven persons to our Board of Directors Quentin BlackfordForWITHHOLD — 13 of 14 BlackRock fundsFor—
PROCEPT BIOROBOTICS CORPORATION2026-06-09Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.AgainstFOR — 21 of 24 BlackRock fundsAgainstApproved, 73.1% support
IVANHOE ELECTRIC INC.2026-06-04Election of Directors Priya PatilForAGAINST — 13 of 14 BlackRock fundsFor—
GRID DYNAMICS HOLDINGS, INC.2025-12-23DIRECTOR: Eric BenhamouForABSTAIN — 17 of 19 BlackRock fundsFor—
GRID DYNAMICS HOLDINGS, INC.2025-12-23DIRECTOR: Weihang WangAbstainFOR — 17 of 19 BlackRock fundsAgainst—
GRID DYNAMICS HOLDINGS, INC.2025-12-23The approval of 3,500,000 additional shares under the Grid Dynamics Holdings, Inc. 2020 Equity Incentive Plan.AgainstFOR — 17 of 19 BlackRock fundsAgainstApproved, 68.4% support
SOUTHERN MISSOURI BANCORP, INC.2025-10-20Election of Directors: Charles R. LoveAgainstFOR — 13 of 14 BlackRock fundsAgainst—
WEATHERFORD INTERNATIONAL PLC2026-06-11Election of Directors Benjamin C. Duster, IVForAGAINST — 27 of 32 BlackRock fundsFor—
WEATHERFORD INTERNATIONAL PLC2026-06-11Election of Directors Jacqueline C. MutschlerForAGAINST — 27 of 32 BlackRock fundsFor—
WEATHERFORD INTERNATIONAL PLC2026-06-11Election of Directors Neal P. GoldmanForAGAINST — 27 of 32 BlackRock fundsFor—
PAR PACIFIC HOLDINGS, INC.2026-04-30DIRECTOR: Patricia MartinezAbstainFOR — 20 of 23 BlackRock fundsAgainst—
NUTEX HEALTH INC.2026-04-23DIRECTOR: Scott J. SaundersAbstainFOR — 8 of 8 BlackRock fundsAgainst—
BJ'S WHOLESALE CLUB HOLDINGS, INC.2026-06-18Shareholder Vote on a shareholder proposal regarding a report on greenhouse gas emissions reduction efforts, if properly presented at the meeting.ForAGAINST — 26 of 31 BlackRock fundsAgainst—
LIFE TIME GROUP HOLDINGS, INC.2026-04-22DIRECTOR: J. Kristofer GalashanAbstainFOR — 12 of 13 BlackRock fundsAgainst—
LIFE TIME GROUP HOLDINGS, INC.2026-04-22DIRECTOR: Jonathan CosletAbstainFOR — 12 of 13 BlackRock fundsAgainst—
IMMUNITYBIO, INC.2026-06-09Election of Directors Linda Maxwell, M.D.ForWITHHOLD — 12 of 13 BlackRock fundsFor—
ACADIA PHARMACEUTICALS INC.2026-05-29To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Edmund P. Harrigan, M.D.ForWITHHOLD — 19 of 22 BlackRock fundsForPassed (calculated), 85.4% support
UNITED STATES LIME & MINERALS, INC.2026-05-01To approve, on a non-binding advisory basis, the Company's executive compensation.ForAGAINST — 19 of 22 BlackRock fundsForApproved, 87.9% support
OSI SYSTEMS, INC.2025-12-11Election of Directors James B. HawkinsAgainstFOR — 16 of 18 BlackRock fundsAgainst—
OSI SYSTEMS, INC.2025-12-11Election of Directors Kelli BernardAgainstFOR — 16 of 18 BlackRock fundsAgainst—
UNITED STATES ANTIMONY CORPORATION2026-06-12To elect each of the seven directors named in the Proxy Statement for a term of one year; Joseph A. CarrabbaWithholdFOR — 12 of 13 BlackRock fundsAgainst—
UNITED STATES ANTIMONY CORPORATION2026-06-12To elect each of the seven directors named in the Proxy Statement for a term of one year; Michael A. McManusWithholdFOR — 12 of 13 BlackRock fundsAgainst—
IONQ, INC.2026-06-16To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal. William F. ScannellForWITHHOLD — 22 of 26 BlackRock fundsFor—
HENRY SCHEIN, INC.2026-05-21Shareholder Proposal to approve, by non-binding vote, a shareholder proposal to Govern by Majority Vote.ForAGAINST — 27 of 33 BlackRock fundsAgainstApproved, 57.6% support
HENRY SCHEIN, INC.2026-05-21Election of Incumbent Directors Max LinForAGAINST — 27 of 33 BlackRock fundsFor—
SANMINA CORPORATION2026-03-09To elect eight directors of Sanmina Corporation: Mythili SankaranAgainstFOR — 18 of 21 BlackRock fundsAgainstPassed (calculated), 56.9% support
MAXLINEAR, INC.2026-05-20To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2025, as set forth in the proxy statement.AgainstFOR — 24 of 29 BlackRock fundsAgainstApproved, 85.0% support
THE GEO GROUP, INC.2026-04-28Advisory vote to approve named executive officer compensation.ForAGAINST — 21 of 25 BlackRock fundsForApproved, 71.6% support
SKYWEST, INC.2026-05-05Shareholder A shareholder proposal regarding collective bargaining policy.ForAGAINST — 18 of 21 BlackRock fundsAgainst—
AMC ENTERTAINMENT HOLDINGS, INC.2025-12-10Say on Pay - An advisory vote to approve the compensation of named executive officers.ForAGAINST — 18 of 21 BlackRock fundsForApproved, 52.8% support
BANK OF HAWAII CORPORATION2026-04-24Say on Pay - An advisory vote on executive compensation.AgainstFOR — 24 of 29 BlackRock fundsAgainstPassed (calculated), 59.8% support
UROGEN PHARMA LTD2025-08-26To elect to the Board of Directors the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders. Arie Belldegrun, M.D.ForWITHHOLD — 7 of 7 BlackRock fundsFor—
EOS ENERGY ENTERPRISES INC2026-06-03Non-binding advisory vote to approve our named executive officer compensation.AgainstFOR — 24 of 29 BlackRock fundsAgainstApproved, 75.3% support
REZOLUTE, INC.2025-11-19DIRECTOR: Nerissa KreherAbstainFOR — 7 of 7 BlackRock fundsAgainst—
REZOLUTE, INC.2025-11-19DIRECTOR: Philippe FauchetAbstainFOR — 7 of 7 BlackRock fundsAgainst—
PLAYSTUDIOS, INC2025-07-22DIRECTOR: Jason KrikorianForABSTAIN — 7 of 7 BlackRock fundsFor—
PLAYSTUDIOS, INC2025-07-22DIRECTOR: Joe HorowitzForABSTAIN — 7 of 7 BlackRock fundsFor—
CVR ENERGY, INC.2026-06-04DIRECTOR: Julia H. VolivaAbstainFOR — 17 of 20 BlackRock fundsAgainst—
ACADIAN ASSET MANAGEMENT INC.2026-06-11Election of Directors: Andrew KimAgainstFOR — 14 of 16 BlackRock fundsAgainstElected, 85.0% support
ACADIAN ASSET MANAGEMENT INC.2026-06-11Election of Directors: John PaulsonAgainstFOR — 14 of 16 BlackRock fundsAgainstElected, 90.6% support
SAREPTA THERAPEUTICS, INC.2026-06-04To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Deirdre ConnellyForAGAINST — 23 of 28 BlackRock fundsForElected, 79.0% support
ALPHA METALLURGICAL RESOURCES, INC.2026-05-06Election of six director nominees, each of whom has been nominated by our board of directors to serve for a term of one year. Joanna Baker de NeufvilleWithholdFOR — 17 of 20 BlackRock fundsAgainst—
INCYTE CORPORATION2026-06-08Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.ForAGAINST — 54 of 73 BlackRock fundsForApproved, 83.9% support
ARROWHEAD PHARMACEUTICALS, INC.2026-03-19Advisory Vote to Approve Executive Compensation.ForAGAINST — 24 of 30 BlackRock fundsFor—
THE CHEFS' WAREHOUSE, INC.2026-05-08To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the 2026 Proxy Statement.ForAGAINST — 22 of 27 BlackRock fundsForApproved, 51.0% support
LUMEN TECHNOLOGIES, INC.2026-05-20Shareholder Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill.ForAGAINST — 19 of 23 BlackRock fundsAgainstNot approved, 47.8% support
MIAMI INTL HLDGS INC2026-06-16The approval, on a non-binding advisory basis, of the compensation of our named executive officers.ForAGAINST — 19 of 23 BlackRock fundsForPassed (calculated), 73.9% support
IPG PHOTONICS CORPORATION2026-05-12Advisory Approval of our Executive CompensationAgainstFOR — 27 of 34 BlackRock fundsAgainstPassed (calculated), 71.6% support
ARROWHEAD PHARMACEUTICALS, INC.2026-03-19Election of Directors Michael S. PerryForAGAINST — 16 of 19 BlackRock fundsFor—
AMERIS BANCORP2026-05-21Election of 10 directors to serve until the Company's 2027 Annual Meeting of Shareholders. William H. SternAgainstFOR — 16 of 19 BlackRock fundsAgainst—
BGC GROUP INC.2025-11-12DIRECTOR: Arthur U. MbanefoAbstainFOR — 16 of 19 BlackRock fundsAgainst—
BGC GROUP INC.2025-11-12DIRECTOR: David P. RichardsAbstainFOR — 16 of 19 BlackRock fundsAgainst—
BGC GROUP INC.2025-11-12DIRECTOR: Linda A. BellAbstainFOR — 16 of 19 BlackRock fundsAgainst—
BGC GROUP INC.2025-11-12DIRECTOR: William D. AddasAbstainFOR — 16 of 19 BlackRock fundsAgainst—
MAXLINEAR, INC.2026-05-20Election of the two nominees for Class II director named in the proxy statement, each to hold office until the 2029 annual meeting of stockholders and until their respective successors are duly elected and qualified. Theodore L. Tewksbury, Ph.D.AgainstFOR — 16 of 19 BlackRock fundsAgainst—
MIAMI INTL HLDGS INC2026-06-16DIRECTOR: Talal Jassim Al-BaharForABSTAIN — 13 of 15 BlackRock fundsFor—
AVEANNA HEALTHCARE HOLDINGS INC.2026-05-29To elect the three Class II director nominees identified in the accompanying Proxy Statement to the Board of Directors of the Company, each to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders. Steven E. RodgersForWITHHOLD — 13 of 15 BlackRock fundsFor—
ASANA, INC.2026-06-08DIRECTOR: K. Anderson-CoppermanForABSTAIN — 13 of 15 BlackRock fundsFor—
NAVITAS SEMICONDUCTOR CORPORATION2026-06-25The approval of an advisory resolution on the compensation of our named executive officers.AgainstFOR — 21 of 26 BlackRock fundsAgainstApproved, 77.3% support
NUSCALE POWER CORPORATION2026-05-29An advisory vote to approve the Company's executive compensation.AgainstFOR — 21 of 26 BlackRock fundsAgainstPassed (calculated), 96.3% support
SAREPTA THERAPEUTICS, INC.2026-06-04Advisory vote to approve, on a non-binding basis, named executive officer compensationAgainstFOR — 31 of 40 BlackRock fundsAgainstApproved, 66.9% support
RED CAT HOLDINGS INC2026-06-18Election of five (5) Directors. Christopher R. MoeForWITHHOLD — 10 of 11 BlackRock fundsFor—
RED CAT HOLDINGS INC2026-06-18Election of five (5) Directors. General (R) Paul E. Funk IIWithholdFOR — 10 of 11 BlackRock fundsAgainst—
STITCH FIX, INC.2025-12-11Advisory vote to approve executive compensation.ForAGAINST — 13 of 15 BlackRock fundsForApproved, 87.2% support
STITCH FIX, INC.2025-12-11Election of Directors Kofi Amoo-GottfriedWithholdFOR — 10 of 11 BlackRock fundsAgainst—
INCYTE CORPORATION2026-06-08Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jean-Jacques BienaiméForAGAINST — 44 of 60 BlackRock fundsFor—
BRIGHTSPRING HEALTH SERVICES, INC.2026-05-21Election of Class II directors Steve MillerWithholdFOR — 15 of 18 BlackRock fundsAgainst—
TRAVERE THERAPEUTICS, INC.2026-05-19DIRECTOR: Roy BaynesForABSTAIN — 15 of 18 BlackRock fundsFor—
THE CHEFS' WAREHOUSE, INC.2026-05-08Election of Directors Aylwin LewisForAGAINST — 15 of 18 BlackRock fundsFor—
CORVEL CORPORATION2025-08-07DIRECTOR: R. Judd JessupForABSTAIN — 15 of 18 BlackRock fundsFor—
CORVEL CORPORATION2025-08-07DIRECTOR: Steven J. HamerslagAbstainFOR — 15 of 18 BlackRock fundsAgainst—
MCGRATH RENTCORP2026-06-03Election of Directors : Each to be elected and to serve until the 2027 Annual Meeting of Shareholders or until their successors are elected and qualified. Bradley M. ShusterWithholdFOR — 15 of 18 BlackRock fundsAgainst—
WORTHINGTON ENTERPRISES, INC.2025-09-23Elect four directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: Billy R. VickersAgainstFOR — 15 of 18 BlackRock fundsAgainstPassed (calculated), 96.1% support
WORTHINGTON ENTERPRISES, INC.2025-09-23Elect four directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: David P. BlomAgainstFOR — 15 of 18 BlackRock fundsAgainstPassed (calculated), 90.4% support
BIOCRYST PHARMACEUTICALS, INC.2026-06-11To hold a non-binding, advisory vote regarding executive compensation.ForAGAINST — 20 of 25 BlackRock fundsForApproved, 68.9% support
HARMONY BIOSCIENCES HOLDINGS, INC.2026-05-14DIRECTOR: Troy IgnelziForABSTAIN — 15 of 18 BlackRock fundsFor—
BANKWELL FINANCIAL GROUP, INC.2026-05-20Election of Directors: Eric J. DaleForWITHHOLD — 6 of 6 BlackRock fundsForPassed (calculated), 89.7% support
BANKWELL FINANCIAL GROUP, INC.2026-05-20Election of Directors: Kevin D. LeitãoForWITHHOLD — 6 of 6 BlackRock fundsFor—
BANKWELL FINANCIAL GROUP, INC.2026-05-20Election of Directors: Todd H. LampertForWITHHOLD — 6 of 6 BlackRock fundsForPassed (calculated), 89.6% support
TEMPUS AI, INC.2026-05-21DIRECTOR: Wayne A.I. Frederick MDForABSTAIN — 17 of 21 BlackRock fundsFor—
XOMETRY, INC.2026-06-16To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029. Katharine WeymouthWithholdFOR — 12 of 14 BlackRock fundsAgainst—
AVEANNA HEALTHCARE HOLDINGS INC.2026-05-29To approve, on an advisory, non-binding, basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement.ForAGAINST — 19 of 24 BlackRock fundsForPassed (calculated), 89.1% support
NEWMARK GROUP, INC.2025-12-30Approval, on an advisory basis, of executive compensation.ForAGAINST — 19 of 24 BlackRock fundsForApproved, 77.5% support
FMC CORPORATION2026-04-28Approval, by non-binding vote, of executive compensation.ForAGAINST — 32 of 43 BlackRock fundsFor—
MACY'S INC.2026-05-15Election of Directors: Deirdre P. ConnellyForAGAINST — 21 of 27 BlackRock fundsForPassed (calculated), 77.8% support
THE GEO GROUP, INC.2026-04-28Election of Directors Jack BrewerForAGAINST — 14 of 17 BlackRock fundsFor—
SONIC AUTOMOTIVE, INC.2026-04-29Election of Directors Keri A. KaiserAgainstFOR — 14 of 17 BlackRock fundsAgainst—
SONIC AUTOMOTIVE, INC.2026-04-29Election of Directors R. Eugene TaylorForAGAINST — 14 of 17 BlackRock fundsFor—
SONIC AUTOMOTIVE, INC.2026-04-29Election of Directors William I. BelkForAGAINST — 14 of 17 BlackRock fundsFor—
EOS ENERGY ENTERPRISES INC2026-06-03Election of Directors Claude DembyAgainstFOR — 14 of 17 BlackRock fundsAgainst—
TIPTREE INC.2025-12-03A proposal to approve one or more adjournments of the special meeting, if necessary, to solicit additional proxies, in the event that there are insufficient votes to approve the Merger Proposal.ForAGAINST — 14 of 17 BlackRock fundsFor—
TIPTREE INC.2025-12-03A proposal to approve the merger and the other transactions contemplated by that certain Agreement and Plan of Merger, dated as of September 26, 2025 (the "Merger Agreement"), among Tiptree Inc., a Maryland corporation, The Fortegra Group, Inc., a Delaware corporation ("Fortegra"), DB Insurance Co.,ForAGAINST — 14 of 17 BlackRock fundsFor—
WAVE LIFE SCIENCES LTD.2025-08-05To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd.AgainstFOR — 14 of 17 BlackRock fundsAgainstApproved, 78.2% support
MIMEDX GROUP, INC.2026-06-10Election of Directors James L. BiermanAgainstFOR — 14 of 17 BlackRock fundsAgainst—
MIMEDX GROUP, INC.2026-06-10Election of Directors K. Todd NewtonAgainstFOR — 14 of 17 BlackRock fundsAgainst—
GUARDANT HEALTH, INC.2026-06-17Election of Class II Directors Ian ClarkWithholdFOR — 16 of 20 BlackRock fundsAgainst—
MADRIGAL PHARMACEUTICALS INC.2026-06-17Advisory vote to approve executive compensationAgainstFOR — 22 of 29 BlackRock fundsAgainstApproved, 97.1% support
C3.AI, INC.2025-10-03Advisory vote to approve the compensation of our named executive officers.ForAGAINST — 22 of 29 BlackRock fundsForApproved, 86.2% support
RAMACO RESOURCES, INC.2026-06-10To approve, on an advisory basis, the compensation paid by the Company to its named executive officers.AgainstFOR — 16 of 20 BlackRock fundsAgainstPassed (calculated), 92.3% support
PAGSEGURO DIGITAL LTD.2026-05-27Election of Director: Luis FriasForAGAINST — 11 of 13 BlackRock fundsFor—
PAGSEGURO DIGITAL LTD.2026-05-27Election of Director: Maria Judith de BritoAgainstFOR — 11 of 13 BlackRock fundsAgainst—
COEUR MINING, INC.2026-01-27The Charter Amendment Proposal - To consider and vote on the proposal to approve the amendment to the Coeur Certificate of Incorporation, as amended (the ''Charter Amendment''), to increase the number of authorized shares of Coeur Common Stock from 900,000,000 shares to 1,300,000,000 shares (the ''CAgainstFOR — 15 of 19 BlackRock fundsAgainst—
COEUR MINING, INC.2026-01-27The Stock Issuance Proposal - To consider and vote on the proposal to approve the issuance of shares of Coeur Common Stock to New Gold shareholders in connection with the Arrangement (the ''Stock Issuance Proposal'').AgainstFOR — 15 of 19 BlackRock fundsAgainst—
ONEMAIN HOLDINGS, INC.2026-06-16To elect two Class I director nominees to serve until the 2029 Annual Meeting of Stockholders. Phyllis R. CaldwellAgainstFOR — 21 of 28 BlackRock fundsAgainst—
RADNET, INC.2026-06-02DIRECTOR: Laura P. JacobsAbstainFOR — 17 of 22 BlackRock fundsAgainst—
MIRUM PHARMACEUTICALS, INC.2026-06-15To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Timothy WalbertForWITHHOLD — 13 of 16 BlackRock fundsFor—
MIRUM PHARMACEUTICALS, INC.2026-06-15To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. William FaireyWithholdFOR — 13 of 16 BlackRock fundsAgainst—
BOOT BARN HOLDINGS, INC.2025-08-27Election of Directors: Brenda I. MorrisWithholdFOR — 15 of 19 BlackRock fundsAgainstElected, 97.9% support
BOOT BARN HOLDINGS, INC.2025-08-27Election of Directors: Lisa G. LaubeForWITHHOLD — 15 of 19 BlackRock fundsForElected, 78.3% support
LEMONADE, INC.2026-06-03DIRECTOR: Michael EisenbergForABSTAIN — 13 of 16 BlackRock fundsFor—
F&G ANNUITIES & LIFE, INC.2026-06-24DIRECTOR: John D. RoodAbstainFOR — 13 of 16 BlackRock fundsAgainst—
LIVE OAK BANCSHARES, INC.2026-05-19DIRECTOR: David G. LuchtAbstainFOR — 13 of 16 BlackRock fundsAgainst—
LIVE OAK BANCSHARES, INC.2026-05-19DIRECTOR: Miltom E. PettyAbstainFOR — 13 of 16 BlackRock fundsAgainst—
LIVE OAK BANCSHARES, INC.2026-05-19DIRECTOR: Neil L. UnderwoodAbstainFOR — 13 of 16 BlackRock fundsAgainst—
LIVE OAK BANCSHARES, INC.2026-05-19DIRECTOR: William H. CameronAbstainFOR — 13 of 16 BlackRock fundsAgainst—
LIVE OAK BANCSHARES, INC.2026-05-19DIRECTOR: William L. Williams IIIAbstainFOR — 13 of 16 BlackRock fundsAgainst—
LIVE OAK BANCSHARES, INC.2026-05-19DIRECTOR: Yousef A. ValineAbstainFOR — 13 of 16 BlackRock fundsAgainst—
LIVE OAK BANCSHARES, INC.2026-05-19Omnibus Stock Incentive Plan. Proposal to approve the Live Oak Bancshares, Inc. 2026 Omnibus Stock Incentive Plan.AgainstFOR — 13 of 16 BlackRock fundsAgainstPassed (calculated), 73.2% support
RYERSON HOLDING CORPORATION2026-04-30The election of directors Jacob KotzubeiForWITHHOLD — 13 of 16 BlackRock fundsFor—
EVERQUOTE, INC.2026-06-04To approve an amendment to the Company's Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation.AgainstFOR — 13 of 16 BlackRock fundsAgainstApproved, 78.0% support
ROOT, INC.2026-06-03To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to allow for exculpation of certain officers.ForAGAINST — 13 of 16 BlackRock fundsForApproved, 87.1% support
ROOT, INC.2026-06-03To elect three Class III directors, Lawrence Hilsheimer, Alexander Timm and Douglas Ulman, each to hold office until our Annual Meeting of Stockholders in 2029. Douglas UlmanForAGAINST — 13 of 16 BlackRock fundsFor—
ENOVIX CORPORATION2026-06-11To approve, on an advisory basis, the compensation of our named executive officers.AgainstFOR — 17 of 22 BlackRock fundsAgainstApproved, 82.5% support
CONTANGO ORE, INC.2026-03-17The Share Increase Proposal - To approve the increase of the number of authorized Contango Shares from 45,000,000 shares to 250,000,000 shares and the related amendment to the Certificate of Incorporation of Contango, as amended (the "Charter") that will be set forth in a Certificate of Amendment toAgainstFOR — 5 of 5 BlackRock fundsAgainst—
RAMACO RESOURCES, INC.2026-06-10DIRECTOR: Bryan H. LawrenceAbstainFOR — 13 of 16 BlackRock fundsAgainst—
CHORD ENERGY CORPORATION2026-04-29To elect eleven directors to serve until the 2027 Annual Meeting: Samantha McKinneyAgainstFOR — 22 of 30 BlackRock fundsAgainstElected, 97.8% support
CRYOPORT, INC.2026-06-05DIRECTOR: Linda BaddourAbstainFOR — 8 of 9 BlackRock fundsAgainst—
SOUNDHOUND AI, INC.2026-05-22DIRECTOR: Diana SrokaAbstainFOR — 12 of 15 BlackRock fundsAgainst—
SOUNDHOUND AI, INC.2026-05-22DIRECTOR: Larry MarcusAbstainFOR — 12 of 15 BlackRock fundsAgainst—
NUSCALE POWER CORPORATION2026-05-29DIRECTOR: Stuart HarshawForABSTAIN — 14 of 18 BlackRock fundsFor—
GLOBAL INDUSTRIAL COMPANY2026-06-01DIRECTOR: Paul S. PearlmanAbstainFOR — 12 of 15 BlackRock fundsAgainst—
UROGEN PHARMA LTD2026-06-22To approve the amendment and restatement of the Articles of Association of the Company to, among other things, tie eligibility for shareholder proposals to the requirements under the Israeli Companies Law.AgainstFOR — 10 of 12 BlackRock fundsAgainstApproved, 68.2% support
UROGEN PHARMA LTD2026-06-22To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders. Arie Belldegrun, M.D.ForAGAINST — 10 of 12 BlackRock fundsFor—
CLEARPOINT NEURO, INC.2026-05-20An advisory (non-binding) vote to approve the compensation of ClearPoint Neuro, Inc.'s named executive officers.AgainstFOR — 10 of 12 BlackRock fundsAgainstApproved, 95.2% support
APOGEE THERAPEUTICS, INC.2026-06-09DIRECTOR: William (BJ) Jones, Jr.ForABSTAIN — 12 of 15 BlackRock fundsFor—
DOXIMITY, INC2025-08-28To approve, on a non-binding advisory basis, the compensation paid to the Company's named executive officers for the fiscal year ended March 31, 2025.ForAGAINST — 29 of 42 BlackRock fundsForPassed (calculated), 96.4% support
FMC CORPORATION2026-04-28Election of eleven Directors (nominees 1a. -1j.) to serve for a one-year term. K'Lynne JohnsonForAGAINST — 22 of 31 BlackRock fundsFor—
CONSTRUCTION PARTNERS INC2026-03-24Proposal to elect two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders. Craig JenningsWithholdFOR — 11 of 14 BlackRock fundsAgainst—
FLUENCE ENERGY, INC.2026-03-12DIRECTOR: Axel MeierForABSTAIN — 11 of 14 BlackRock fundsFor—
FLUENCE ENERGY, INC.2026-03-12DIRECTOR: Letitia T. MendozaForABSTAIN — 11 of 14 BlackRock fundsFor—
FLUENCE ENERGY, INC.2026-03-12DIRECTOR: Ricardo FaluForABSTAIN — 11 of 14 BlackRock fundsFor—
FLUENCE ENERGY, INC.2026-03-12DIRECTOR: Ruth GratzkeForABSTAIN — 11 of 14 BlackRock fundsFor—
SCHOLAR ROCK HOLDING CORPORATION2026-06-04DIRECTOR: Kristina BurowForABSTAIN — 14 of 19 BlackRock fundsFor—
DYNE THERAPEUTICS, INC.2026-06-05To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified. Jason RhodesWithholdFOR — 14 of 19 BlackRock fundsAgainst—
ALECTOR, INC.2026-06-17Advisory vote on executive compensation.AgainstFOR — 12 of 16 BlackRock fundsAgainstApproved, 95.9% support
AVIDITY BIOSCIENCES, INC.2026-02-26To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers in connection with the transactions contemplated by the Merger Agreement and the Separation Agreement.ForAGAINST — 23 of 34 BlackRock fundsForApproved, 82.4% support
VIKING THERAPEUTICS INC2026-05-19TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.ForAGAINST — 25 of 38 BlackRock fundsForApproved, 70.2% support
GRINDR INC.2025-07-30DIRECTOR: J. Michael Gearon, Jr.AbstainFOR — 10 of 13 BlackRock fundsAgainst—
GRINDR INC.2025-07-30DIRECTOR: James Fu Bin LuAbstainFOR — 10 of 13 BlackRock fundsAgainst—
SPROUT SOCIAL, INC.2026-05-20To conduct an advisory vote to approve the compensation of our named executive officers.AgainstFOR — 15 of 21 BlackRock fundsAgainstApproved, 96.5% support
PROTAGONIST THERAPEUTICS, INC.2026-06-17DIRECTOR: L.T. Williams, MD, PhDAbstainFOR — 19 of 28 BlackRock fundsAgainst—
NOVOCURE LIMITED2026-06-03The approval of our amended and restated 2024 Omnibus Incentive Plan.AgainstFOR — 13 of 18 BlackRock fundsAgainstApproved, 50.3% support
RUBRIK, INC.2026-06-03DIRECTOR: Ravi MhatreAbstainFOR — 23 of 36 BlackRock fundsAgainst—
ARCHER AVIATION INC.2026-06-26Approval of the redomestication of the Company from Delaware to Texas by conversion.AgainstFOR — 11 of 15 BlackRock fundsAgainstPassed (calculated), 84.0% support
ARCHER AVIATION INC.2026-06-26Approval, on a non-binding advisory basis, of the compensation of our named executive officers.AgainstFOR — 17 of 25 BlackRock fundsAgainstApproved, 82.0% support
SKYWORKS SOLUTIONS, INC.2026-05-13To elect the following nine individuals nominated to serve as directors of the Company with terms expiring at the next Annual Meeting of Stockholders. Christine KingForAGAINST — 29 of 47 BlackRock fundsFor—
SKYWORKS SOLUTIONS, INC.2026-05-13To elect the following nine individuals nominated to serve as directors of the Company with terms expiring at the next Annual Meeting of Stockholders. Maryann TurckeForAGAINST — 29 of 47 BlackRock fundsFor—
CARIS LIFE SCIENCES, INC.2026-06-04DIRECTOR: Peter M. CastlemanForABSTAIN — 16 of 24 BlackRock fundsFor—
GREENE COUNTY BANCORP, INC.2025-11-01To consider and approve a non-binding advisory resolution regarding the compensation of the Company's named executive officers.ForAGAINST — 9 of 12 BlackRock fundsForPassed (calculated), 91.9% support
ATEA PHARMACEUTICALS, INC.2026-06-18DIRECTOR: Jerome Adams, MD, MPHAbstainFOR — 9 of 12 BlackRock fundsAgainst—
VIKING THERAPEUTICS INC2026-05-19DIRECTOR: J. Matthew SingletonForABSTAIN — 18 of 28 BlackRock fundsFor—
NOVAGOLD RESOURCES INC.2026-05-14Approval of Non-Binding Advisory Vote on Executive Compensation - To consider and, if deemed advisable, pass a non-binding resolution approving the compensation of the Company's Named Executive Officers.AgainstFOR — 17 of 26 BlackRock fundsAgainst—
USCB FINANCIAL HOLDINGS INC2026-05-26Election of Directors: NOMINEES for a one-year term expiring in 2027: Aida Levitan, Ph.D.WithholdFOR — 7 of 9 BlackRock fundsAgainst—
CHEWY, INC.2025-07-10To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.ForAGAINST — 18 of 29 BlackRock fundsForPassed (calculated), 94.3% support
EDITAS MEDICINE, INC.2026-06-17DIRECTOR: Bernadette ConnaughtonForABSTAIN — 8 of 11 BlackRock fundsFor—
VISTANCE NETWORKS, INC.2026-05-07Election of eight directors: Joanne M. MaguireAgainstFOR — 19 of 32 BlackRock fundsAgainstPassed (calculated), 89.4% support
TG THERAPEUTICS, INC.2026-06-11DIRECTOR: Kenneth HobermanForABSTAIN — 16 of 27 BlackRock fundsFor—
EVI INDUSTRIES, INC.2025-12-15Non-binding advisory vote on Named Executive Officer compensation.ForAGAINST — 6 of 8 BlackRock fundsForPassed (calculated), 78.1% support
VIEMED HEALTHCARE, INC.2026-06-04DIRECTOR: Sabrina HeltzAbstainFOR — 7 of 10 BlackRock fundsAgainst—
BROOKFIELD BUSINESS CORPORATION2026-01-13BBUC Arrangement Resolution set out in the Circular.AgainstFOR — 7 of 10 BlackRock fundsAgainst—
ROKU, INC.2026-06-11Advisory vote to approve our named executive officer compensation.AgainstFOR — 23 of 45 BlackRock fundsAgainstApproved, 85.5% support
BANK7 CORP.2026-05-20Election of Directors Gary D. WhitcombAgainstFOR — 6 of 9 BlackRock fundsAgainst—
HINGE HEALTH, INC.2026-06-03DIRECTOR: Teddie WardiForABSTAIN — 5 of 8 BlackRock fundsFor—

Download all 218 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 95.7% of this fund’s 4,940 such votes could be given a sector; the other 210 (4.3%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care1,17870.6%
Consumer Discretionary915182.0%
Technology75240.5%
Industrials67971.0%
Finance59330.5%
Utilities12000.0%
Energy11500.0%
Basic Materials10200.0%
Real Estate8500.0%
Telecommunications8111.2%
Miscellaneous7900.0%
Consumer Staples3100.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3,3418
Say-on-Pay6243
Audit-related5770
Compensation2060
Corporate Governance908
Capital Structure620
Extraordinary Transactions532
Shareholder Rights and Defenses4912
Environment or Climate33
Human Rights or Human Capital/workforce33

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
BLOOM ENERGY CORPORATIONMay 21, 2026$18M80
LUMENTUM HOLDINGS INC.November 19, 2025$13M110
NEXTRACKER INC.August 18, 2025$7M50
MODERNA, INC.November 12, 2025$6M20
GLAUKOS CORPORATIONMay 28, 2026$6M40
GUARDANT HEALTH, INC.June 17, 2026$6M50
ADVANCED ENERGY INDUSTRIES, INC.May 7, 2026$6M140
THE ENSIGN GROUP, INC.May 13, 2026$6M60

Notable votes against management

MeetingCompanyProposalFundMgmt
April 28, 2026THE BRINK'S COMPANYAct upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposalAgainstFor
March 9, 2026SANMINA CORPORATIONTo consider and vote upon the stockholder proposal entitled ''Independent Board Chairman,'' requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
May 5, 2026SKYWEST, INC.A shareholder proposal regarding collective bargaining policy. Shareholder proposalForAgainst
May 13, 2026SKYWORKS SOLUTIONS, INC.To approve a stockholder proposal regarding greenhouse gas emission reduction efforts report. Shareholder proposalAgainstFor
April 29, 2026BORGWARNER INC.Vote on stockholder proposal regarding action by written consent. Shareholder proposalAgainstFor
June 18, 2026BJ'S WHOLESALE CLUB HOLDINGS, INC.Vote on a shareholder proposal regarding adopting a majority voting standard, if properly presented at the meeting. Shareholder proposalAgainstFor
June 18, 2026BJ'S WHOLESALE CLUB HOLDINGS, INC.Vote on a shareholder proposal regarding a report on greenhouse gas emissions reduction efforts, if properly presented at the meeting. Shareholder proposalForAgainst
May 20, 2026LUMEN TECHNOLOGIES, INC.Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposalForAgainst
May 14, 2026CALIX, INC.To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposalForAgainst
May 21, 2026HENRY SCHEIN, INC.Proposal to approve, by non-binding vote, a shareholder proposal to Govern by Majority Vote. Shareholder proposalForAgainst
July 30, 2025GRINDR INC.Stockholder proposal regarding adoption of a human rights policy covering freedom of association and collective bargaining. Shareholder proposalAgainstFor
May 12, 2026GROUP 1 AUTOMOTIVE, INC.Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (4 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

5,010 ballot items at 630 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, BlackRock Advantage Small Cap Growth Fund (CSGEX) voted at 630 shareholder meetings of 608 companies, on 5,010 ballot items in all. Where management made a recommendation, the fund followed it on 97.2% of the items and voted against it 40 times. Its most frequent area of disagreement was shareholder rights and defenses (12 of its votes against management). It voted on 25 shareholder proposals. It voted FOR the board's own proposals more often than BlackRock's funds as a whole (94.5% against 93.6%). It voted differently from most BlackRock funds on 218 items. 4 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of BlackRock’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.